Who invested in Symphogen?
Symphogen's investors include Novo Holdings A/S, Essex Woodlands Healthcare Partners, The Danish Growth Fund, Gilde Healthcare and SLS Venture, and 7 more on record.

Denmark · Funded startup
Funding summaryUpdated 26 Oct 2026
$360Mraised across 8 rounds since 2004, from 8 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by finsmes.com
From a historical funding record
From Symphogen's own website: 3 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Symphogen's investors include Novo Holdings A/S, Essex Woodlands Healthcare Partners, The Danish Growth Fund, Gilde Healthcare and SLS Venture, and 7 more on record.
Symphogen has raised $360M across 8 rounds since 2004. One round did not disclose an amount, so the total is a floor.
Symphogen's most recent round was a Debt of $77M in Oct 2015.
Symphogen's largest round on record is $131M (Growth), in Jan 2011.
Symphogen's first round on record, in Nov 2004, was backed by The Danish Growth Fund, Novo Holdings A/S and Essex Woodlands Healthcare Partners and 2 others.
Symphogen's latest named round is a Debt, in Oct 2015.
Symphogen is based in Denmark.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.